Churg-Strauss Syndrome Clinical Trials

30 clinical trials for Churg-Strauss Syndrome across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Ocular Manifestations of Granulomatosis With Polyangiitis. — RECRUITING
Vasculitis Pregnancy Registry — RECRUITING
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis — RECRUITING
VCRC Tissue Repository — RECRUITING
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis — ACTIVE_NOT_RECRUITING · PHASE2
Hydroxychloroquine in ANCA Vasculitis Evaluation — TERMINATED · PHASE4
NUCALA® Special Drug Use Investigation (EGPA, Long-term) — COMPLETED
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis — COMPLETED · PHASE2
Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma — COMPLETED
Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan — COMPLETED
Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921 — COMPLETED · PHASE3
Eosinophilic Granulomatosis With Polyangiitis Cohort — COMPLETED
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome — COMPLETED · PHASE1
VCRC Patient Contact Registry Patient-Reported Data Validation Study — COMPLETED
A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis — COMPLETED · PHASE3
Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome — TERMINATED · PHASE1
Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome — COMPLETED · PHASE1
American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis — OTHER
PRO Development for ANCA Associated Vasculitis — OTHER
Vasculitis Illness Perception (VIP) Study — COMPLETED
Educational Needs of Patients With Systemic Vasculitis — COMPLETED
Reproductive Health in Men and Women With Vasculitis — COMPLETED
Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome — COMPLETED · PHASE2
Rituxan in Churg Strauss Syndrome With Renal Involvement — TERMINATED · PHASE2
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years — COMPLETED · PHASE4
Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides — OTHER · PHASE2
RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides — COMPLETED · NA
CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors — OTHER · PHASE4
Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases — OTHER · NA

Refine this search